{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T13:24:38Z","timestamp":1791033878321,"version":"4.1.0"},"reference-count":60,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Revue de M\u00e9decine Interne"],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1016\/j.revmed.2008.01.025","type":"journal-article","created":{"date-parts":[[2008,4,11]],"date-time":"2008-04-11T15:27:14Z","timestamp":1207927634000},"page":"25-34","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Actualit\u00e9s sur la compr\u00e9hension et le traitement des mastocytoses syst\u00e9miques"],"prefix":"10.1016","volume":"30","author":[{"given":"S.","family":"Georgin-Lavialle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Barete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Suarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Lepelletier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Bodemer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Dubreuil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Lortholary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Hermine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.revmed.2008.01.025_bib1","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0755-4982(05)84013-8","article-title":"Mastocytose syst\u00e9mique","volume":"34","author":"Fain","year":"2005","journal-title":"Presse Med"},{"issue":"6","key":"10.1016\/j.revmed.2008.01.025_bib2","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/00005792-198811000-00001","article-title":"Systemic mast cell disease. Analysis of 58 cases and literature review","volume":"67","author":"Travis","year":"1988","journal-title":"Medicine (Baltimore)"},{"issue":"10","key":"10.1016\/j.revmed.2008.01.025_bib3","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/S1357-2725(99)00078-3","article-title":"Early signaling pathways activated by c-Kit in hematopoietic cells","volume":"31","author":"Linnekin","year":"1999","journal-title":"Int J Biochem Cell Biol"},{"issue":"4","key":"10.1016\/j.revmed.2008.01.025_bib4","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1172\/JCI116761","article-title":"Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product","volume":"92","author":"Furitsu","year":"1993","journal-title":"J Clin Invest"},{"issue":"12","key":"10.1016\/j.revmed.2008.01.025_bib5","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1111\/j.1440-1827.1996.tb03571.x","article-title":"Role of c-kit receptor tyrosine kinase in the development, survival and neoplastic transformation of mast cells","volume":"46","author":"Tsujimura","year":"1996","journal-title":"Pathol Int"},{"issue":"1","key":"10.1016\/j.revmed.2008.01.025_bib6","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jaci.2004.04.046","article-title":"The biology of Kit in disease and the application of pharmacogenetics","volume":"114","author":"Akin","year":"2004","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.revmed.2008.01.025_bib7","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1159\/000048179","article-title":"Kit and c-kit mutations in mastocytosis: a short overview with special reference to novel molecular and diagnostic concepts","volume":"127","author":"Feger","year":"2002","journal-title":"Int Arch Allergy Immunol"},{"issue":"23","key":"10.1016\/j.revmed.2008.01.025_bib8","doi-asserted-by":"crossref","first-page":"10560","DOI":"10.1073\/pnas.92.23.10560","article-title":"Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder","volume":"92","author":"Nagata","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7","key":"10.1016\/j.revmed.2008.01.025_bib9","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1182\/blood-2006-04-015545","article-title":"KIT mutation in mast cells and other bone marrow hematopoietic cell lineages in systemic mast cell disorders: a prospective study of the Spanish Network on Mastocytosis (REMA) in a series of 113 patients","volume":"108","author":"Garcia-Montero","year":"2006","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.revmed.2008.01.025_bib10","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1073\/pnas.96.4.1609","article-title":"Activating and dominant inactivating c-KIT catalytic domain mutations in distinct clinical forms of human mastocytosis","volume":"96","author":"Longley","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"10.1016\/j.revmed.2008.01.025_bib11","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1046\/j.1365-2141.1997.d01-2042.x","article-title":"A new c-kit mutation in a case of aggressive mast cell disease","volume":"96","author":"Pignon","year":"1997","journal-title":"Br J Haematol"},{"issue":"8","key":"10.1016\/j.revmed.2008.01.025_bib12","doi-asserted-by":"crossref","first-page":"3222","DOI":"10.1182\/blood-2003-11-3816","article-title":"A novel form of mastocytosis associated with a transmembrane c-kit mutation and response to imatinib","volume":"103","author":"Akin","year":"2004","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.revmed.2008.01.025_bib13","first-page":"1115","article-title":"Juxtamembrane mutant V560GKit is more sensitive to Imatinib (STI571) compared with wild-type c-kit whereas the kinase domain mutant D816VKit is resistant","volume":"1","author":"Frost","year":"2002","journal-title":"Mol Cancer Ther"},{"issue":"4","key":"10.1016\/j.revmed.2008.01.025_bib14","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.leukres.2005.08.015","article-title":"A novel K509I mutation of KIT identified in familial mastocytosis-in vitro and in vivo responsiveness to imatinib therapy","volume":"30","author":"Zhang","year":"2006","journal-title":"Leuk Res"},{"issue":"3","key":"10.1016\/j.revmed.2008.01.025_bib15","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1053\/j.gastro.2005.06.060","article-title":"Novel germline mutation of KIT associated with familial gastrointestinal stromal tumors and mastocytosis","volume":"129","author":"Hartmann","year":"2005","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1016\/j.revmed.2008.01.025_bib16","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/S0248-8663(03)00141-3","article-title":"Traitement des mastocytoses syst\u00e9miques","volume":"24","author":"Marrache","year":"2003","journal-title":"Rev Med Interne"},{"issue":"10","key":"10.1016\/j.revmed.2008.01.025_bib17","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.revmed.2005.06.004","article-title":"Accident vasculaire c\u00e9r\u00e9bral sur dissection art\u00e9rielle au cours des mastocytoses syst\u00e9miques: une association non-fortuite\u00a0? \u00c0 propos de deux cas","volume":"26","author":"Larroche","year":"2005","journal-title":"Rev Med Interne"},{"issue":"3","key":"10.1016\/j.revmed.2008.01.025_bib18","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/j.1468-3083.2004.00830.x","article-title":"Cutaneous mastocytosis in children: a clinical analysis of 71 cases","volume":"18","author":"Kiszewski","year":"2004","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"15","key":"10.1016\/j.revmed.2008.01.025_bib19","first-page":"1629","article-title":"Mastocytose syst\u00e9mique","volume":"55","author":"Fain","year":"2005","journal-title":"Rev Prat"},{"issue":"2","key":"10.1016\/j.revmed.2008.01.025_bib20","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1159\/000101711","article-title":"Mastocytosis: state of the art","volume":"74","author":"Horny","year":"2007","journal-title":"Pathobiology"},{"issue":"2","key":"10.1016\/j.revmed.2008.01.025_bib21","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1159\/000059404","article-title":"Serum tryptase levels in patients with mastocytosis: correlation with mast cell burden and implication for defining the category of disease","volume":"128","author":"Sperr","year":"2002","journal-title":"Int Arch Allergy Immunol"},{"issue":"3","key":"10.1016\/j.revmed.2008.01.025_bib22","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S0889-8588(05)70300-2","article-title":"Serum tryptase and the laboratory diagnosis of systemic mastocytosis","volume":"14","author":"Schwartz","year":"2000","journal-title":"Hematol Oncol Clin North Am"},{"issue":"4","key":"10.1016\/j.revmed.2008.01.025_bib23","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1046\/j.1365-2141.2002.03944.x","article-title":"Treatment of adult systemic mastocytosis with interferon-alpha: results of a multicentre phase II trial on 20 patients","volume":"119","author":"Casassus","year":"2002","journal-title":"Br J Haematol"},{"issue":"4","key":"10.1016\/j.revmed.2008.01.025_bib24","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1056\/NEJM200101253440415","article-title":"Treatment of systemic mast-cell disease with cladribine","volume":"344","author":"Tefferi","year":"2001","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.revmed.2008.01.025_bib25","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1182\/blood.V96.4.1267","article-title":"Soluble stem cell factor receptor (CD117) and IL-2 receptor alpha chain (CD25) levels in the plasma of patients with mastocytosis: relationships to disease severity and bone marrow pathology","volume":"96","author":"Akin","year":"2000","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.revmed.2008.01.025_bib26","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0145-2126(01)00021-2","article-title":"Diagnosis of mastocytosis: general histopathological aspects, morphological criteria, and immunohistochemical findings","volume":"25","author":"Horny","year":"2001","journal-title":"Leuk Res"},{"issue":"7","key":"10.1016\/j.revmed.2008.01.025_bib27","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0145-2126(01)00038-8","article-title":"Diagnostic criteria and classification of mastocytosis: a consensus proposal","volume":"25","author":"Valent","year":"2001","journal-title":"Leuk Res"},{"issue":"5","key":"10.1016\/j.revmed.2008.01.025_bib28","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1053\/hupa.2001.24319","article-title":"Immunohistochemical properties of bone marrow mast cells in systemic mastocytosis: evidence for expression of CD2, CD117\/Kit, and bcl-x(L)","volume":"32","author":"Jordan","year":"2001","journal-title":"Hum Pathol"},{"issue":"7","key":"10.1016\/j.revmed.2008.01.025_bib29","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0145-2126(01)00041-8","article-title":"Morphologic properties of neoplastic mast cells: delineation of stages of maturation and implication for cytological grading of mastocytosis","volume":"25","author":"Sperr","year":"2001","journal-title":"Leuk Res"},{"issue":"5","key":"10.1016\/j.revmed.2008.01.025_bib30","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1046\/j.1365-2141.2003.04575.x","article-title":"Diagnosis and treatment of systemic mastocytosis: state of the art","volume":"122","author":"Valent","year":"2003","journal-title":"Br J Haematol"},{"issue":"7","key":"10.1016\/j.revmed.2008.01.025_bib31","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0145-2126(01)00050-9","article-title":"Utility of flow cytometric analysis of mast cells in the diagnosis and classification of adult mastocytosis","volume":"25","author":"Escribano","year":"2001","journal-title":"Leuk Res"},{"issue":"1","key":"10.1016\/j.revmed.2008.01.025_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/cyto.b.10072","article-title":"Immunophenotypic analysis of mast cells in mastocytosis: When and how to do it. Proposals of the Spanish Network on Mastocytosis (REMA)","volume":"58","author":"Escribano","year":"2004","journal-title":"Cytometry B Clin Cytom"},{"issue":"9","key":"10.1016\/j.revmed.2008.01.025_bib33","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.1182\/blood-2003-05-1627","article-title":"CHIC2 deletion, a surrogate for FIP1L1-PDGFRA fusion, occurs in systemic mastocytosis associated with eosinophilia and predicts response to imatinib mesylate therapy","volume":"102","author":"Pardanani","year":"2003","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.revmed.2008.01.025_bib34","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1046\/j.1365-2133.2001.04123.x","article-title":"Mastocytosis: recent advances in defining the disease","volume":"144","author":"Hartmann","year":"2001","journal-title":"Br J Dermatol"},{"issue":"5","key":"10.1016\/j.revmed.2008.01.025_bib35","doi-asserted-by":"crossref","first-page":"550","DOI":"10.4161\/cc.6.5.3919","article-title":"Oncogenes in myeloproliferative disorders","volume":"6","author":"Tefferi","year":"2007","journal-title":"Cell Cycle"},{"key":"10.1016\/j.revmed.2008.01.025_bib36","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1146\/annurev.med.55.091902.103822","article-title":"Systemic mastocytosis","volume":"55","author":"Akin","year":"2004","journal-title":"Annu Rev Med"},{"issue":"11","key":"10.1016\/j.revmed.2008.01.025_bib37","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.4065\/77.11.1169","article-title":"Systemic mast cell disease without associated hematologic disorder: a combined retrospective and prospective study","volume":"77","author":"Pardanani","year":"2002","journal-title":"Mayo Clin Proc"},{"issue":"6","key":"10.1016\/j.revmed.2008.01.025_bib38","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/j.1365-2362.2007.01807.x","article-title":"Standards and standardization in mastocytosis: consensus statements on diagnostics, treatment recommendations and response criteria","volume":"37","author":"Valent","year":"2007","journal-title":"Eur J Clin Invest"},{"issue":"3","key":"10.1016\/j.revmed.2008.01.025_bib39","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0145-2126(03)00259-5","article-title":"Response to therapy with interferon alpha-2b and prednisolone in aggressive systemic mastocytosis: report of five cases and review of the literature","volume":"28","author":"Hauswirth","year":"2004","journal-title":"Leuk Res"},{"issue":"4","key":"10.1016\/j.revmed.2008.01.025_bib40","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1359\/jbmr.2002.17.4.567","article-title":"Osteoporosis and bone marrow mastocytosis: dissociation of skeletal responses and mast cell activity during long-term bisphosphonate therapy","volume":"17","author":"Brumsen","year":"2002","journal-title":"J Bone Miner Res"},{"issue":"12","key":"10.1016\/j.revmed.2008.01.025_bib41","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s00277-002-0575-z","article-title":"Mastocytosis: current concepts in diagnosis and treatment","volume":"81","author":"Escribano","year":"2002","journal-title":"Ann Hematol"},{"issue":"7","key":"10.1016\/j.revmed.2008.01.025_bib42","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0145-2126(02)00168-6","article-title":"Aggressive systemic mastocytosis and related mast cell disorders: current treatment options and proposed response criteria","volume":"27","author":"Valent","year":"2003","journal-title":"Leuk Res"},{"issue":"13","key":"10.1016\/j.revmed.2008.01.025_bib43","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1056\/NEJM200103293441303","article-title":"Paroxetine for the prevention of depression induced by high-dose interferon alfa","volume":"344","author":"Musselman","year":"2001","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.revmed.2008.01.025_bib44","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1159\/000048183","article-title":"Abnormal expression of CD antigens in mastocytosis","volume":"127","author":"Escribano","year":"2002","journal-title":"Int Arch Allergy Immunol"},{"issue":"13","key":"10.1016\/j.revmed.2008.01.025_bib45","doi-asserted-by":"crossref","first-page":"4270","DOI":"10.1182\/blood-2003-05-1699","article-title":"Cladribine therapy for systemic mastocytosis","volume":"102","author":"Kluin-Nelemans","year":"2003","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.revmed.2008.01.025_bib46","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0145-2126(03)00185-1","article-title":"Treatment of systemic mast cell disease with 2-chlorodeoxyadenosine","volume":"28","author":"Pardanani","year":"2004","journal-title":"Leuk Res"},{"issue":"3","key":"10.1016\/j.revmed.2008.01.025_bib47","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.exphem.2005.11.015","article-title":"Establishment of a murine model of aggressive systemic mastocytosis\/mast cell leukemia","volume":"34","author":"Demehri","year":"2006","journal-title":"Exp Hematol"},{"issue":"5","key":"10.1016\/j.revmed.2008.01.025_bib48","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1182\/blood.V99.5.1741","article-title":"The c-KIT mutation causing human mastocytosis is resistant to STI571 and other KIT kinase inhibitors; kinases with enzymatic site mutations show different inhibitor sensitivity profiles than wild-type kinases and those with regulatory-type mutations","volume":"99","author":"Ma","year":"2002","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.revmed.2008.01.025_bib49","first-page":"413","article-title":"Persistence of systemic mastocytosis after allogeneic bone marrow transplantation in spite of complete remission of the associated myelodysplastic syndrome","volume":"8","author":"Ronnov-Jessen","year":"1991","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"10.1016\/j.revmed.2008.01.025_bib50","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S1357-4310(96)10061-7","article-title":"Molecular genetics and development of mast cells: implications for molecular medicine","volume":"3","author":"Fodinger","year":"1997","journal-title":"Mol Med Today"},{"issue":"1","key":"10.1016\/j.revmed.2008.01.025_bib51","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1097\/00062752-200401000-00009","article-title":"Clinical, genetic, and therapeutic insights into systemic mast cell disease","volume":"11","author":"Tefferi","year":"2004","journal-title":"Curr Opin Hematol"},{"issue":"2","key":"10.1016\/j.revmed.2008.01.025_bib52","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1158\/0008-5472.CAN-05-2873","article-title":"OSI-930: a novel selective inhibitor of Kit and kinase insert domain receptor tyrosine kinases with antitumor activity in mouse xenograft models","volume":"66","author":"Garton","year":"2006","journal-title":"Cancer Res"},{"issue":"2","key":"10.1016\/j.revmed.2008.01.025_bib53","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1182\/blood-2005-07-3022","article-title":"PKC412 inhibits in vitro growth of neoplastic human mast cells expressing the D816V-mutated variant of KIT: comparison with AMN107, imatinib, and cladribine (2CdA) and evaluation of cooperative drug effects","volume":"107","author":"Gleixner","year":"2006","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.revmed.2008.01.025_bib54","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1182\/blood-2005-04-1568","article-title":"Activity of the tyrosine kinase inhibitor PKC412 in a patient with mast cell leukemia with the D816V KIT mutation","volume":"106","author":"Gotlib","year":"2005","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.revmed.2008.01.025_bib55","doi-asserted-by":"crossref","first-page":"3754","DOI":"10.1182\/blood-2004-06-2189","article-title":"Sensitivity of oncogenic KIT mutants to the kinase inhibitors MLN518 and PD180970","volume":"104","author":"Corbin","year":"2004","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.revmed.2008.01.025_bib56","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1182\/blood-2004-08-3247","article-title":"A novel NF-kappaB inhibitor, IMD-0354, suppresses neoplastic proliferation of human mast cells with constitutively activated c-kit receptors","volume":"105","author":"Tanaka","year":"2005","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.revmed.2008.01.025_bib57","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1182\/blood-2005-06-2433","article-title":"Rapamycin inhibits growth and survival of D816V-mutated c-kit mast cells","volume":"108","author":"Gabillot-Carre","year":"2006","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.revmed.2008.01.025_bib58","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1016\/j.jaci.2007.03.032","article-title":"Omalizumab for the treatment of unprovoked anaphylaxis in patients with systemic mastocytosis","volume":"119","author":"Carter","year":"2007","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.revmed.2008.01.025_bib59","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3324\/haematol.12324","article-title":"How we diagnose and treat WHO-defined systemic mastocytosis in adults","volume":"93","author":"Tefferi","year":"2008","journal-title":"Haematologica"},{"key":"10.1016\/j.revmed.2008.01.025_bib60","doi-asserted-by":"crossref","DOI":"10.1111\/j.1365-2141.2008.07038.x","article-title":"Thalidomide in advanced mastocytosis","author":"Damaj","year":"2008","journal-title":"Br J Haematol"}],"container-title":["La Revue de M\u00e9decine Interne"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866308001112?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866308001112?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:23:14Z","timestamp":1759335794000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0248866308001112"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1]]},"references-count":60,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,1]]}},"alternative-id":["S0248866308001112"],"URL":"https:\/\/doi.org\/10.1016\/j.revmed.2008.01.025","relation":{},"ISSN":["0248-8663"],"issn-type":[{"value":"0248-8663","type":"print"}],"subject":[],"published":{"date-parts":[[2009,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Actualit\u00e9s sur la compr\u00e9hension et le traitement des mastocytoses syst\u00e9miques","name":"articletitle","label":"Article Title"},{"value":"La Revue de M\u00e9decine Interne","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.revmed.2008.01.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}